** Shares of healthcare firm PACS Group fall 30.7% to $29.74
** Hindenburg Research says its five-month investigation revealed that "PACS' 'turnaround' strategy largely boils down to systematically scamming taxpayer-funded healthcare programs"
** The short-seller alleges, citing its investigation, that PACS abused a COVID-era waiver, inappropriately accessing skilled care Medicare benefits for thousands of patients across its national portfolio of facilities
** Hindenburg Research says it believes PACS risks significant regulatory penalties
** PACS Group did not immediately respond to a Reuters request for comment
** Up to last close, stock more than doubled since debut on April 11
(Reporting by Jaspreet Singh in Bengaluru)
((Jaspreet.Singh@thomsonreuters.com ; ))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.